Fairvoy Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Buy
4,768
+326
+7% +$38.2K 0.12% 128
2026
Q1
$534K Sell
4,442
-29
-0.6% -$3.35K 0.13% 137
2025
Q4
$471K Buy
4,471
+348
+8% +$32.7K 0.11% 122
2025
Q3
$346K Sell
4,123
-742
-15% -$61.1K 0.08% 148
2025
Q2
$385K Sell
4,865
-390
-7% -$31K 0.1% 133
2025
Q1
$472K Sell
5,255
-12,202
-70% -$1.14M 0.13% 112
2024
Q4
$1.74M Buy
+17,457
New +$1.8M 0.46% 58

Other funds holding MRK

Fairvoy Private Wealth's MRK Position: Q2 2026 in Review

Fairvoy Private Wealth increased its Merck (MRK) stake by 7.3% in Q2 2026, buying an estimated $38.2K and bringing the position to 4,768 shares worth $613K. The position accounts for 0.12% of the portfolio, ranked #128.

Fairvoy Private Wealth first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.74M in Q4 2024. 925 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fairvoy Private Wealth held 4,768 shares of Merck worth $613K as of Q2 2026.
  • Fairvoy Private Wealth bought 326 Merck shares in Q2 2026, an estimated $38.2K.
  • Merck made up 0.12% of Fairvoy Private Wealth's portfolio in Q2 2026, its #128 holding.
  • Fairvoy Private Wealth first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Fairvoy Private Wealth's Merck position peaked at $1.74M in Q4 2024.
  • 925 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.